Christopher Simon - 13 Jun 2022 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role: President & CEO, Director
Signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon
Issuer symbol: HAE
Transactions as of: 13 Jun 2022
Net transactions value: -$71,865
Form type: 4
Filing time: 15 Jun 2022, 16:27:05 UTC
Previous filing: 23 May 2022
Next filing: 15 Nov 2022
SEC: View on sec.gov

Key filing fact

Christopher Simon filed Form 4 for HAEMONETICS CORP (HAE) on 15 Jun 2022.

Key facts

This page summarizes Christopher Simon's Form 4 filing for HAEMONETICS CORP (HAE).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 15 Jun 2022, 16:27.

Change

Previous filing in this sequence was filed on 23 May 2022.
Current net transaction value: -$71,865.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported transactions

HAE transaction

Common Stock

Sale

Transaction value: $71,865
Shares: -1,148
Change %: -0.53%
Price: $62.60
Shares after: 213,724
Date: 13 Jun 2022
Ownership: Direct
Footnotes: F1, F2

An asterisk next to the price means the reported price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	This number includes unvested RSUs previously reported.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

This number includes unvested RSUs previously reported.